April 12, 2011 |
Low-intensity walking may help people with Parkinson's disease improve their gait and mobility, a new study finds. The study, presented Tuesday at the American Academy of Neurology's annual meeting in Honolulu, compared three different forms of exercise to see which was most beneficial to men and women with Parkinson's disease, which affects motor control. Researchers randomly assigned 67 people with the disease to one of three programs: a low-intensity treadmill walk for 50 minutes; a high-intensity treadmill walk for 30 minutes; and a weight and stretching regimen that included leg presses, extensions and curls.
April 13, 2011 |
In the world of “promising” multiple sclerosis drugs, it’s been quite a week. Two more experimental drugs -- both in pill form, not injected -- are joining the race of new treatments to slow the disease. A study of multiple sclerosis patients who took the drug laquinimod over two years had 23% fewer relapses -- an attack of new symptoms or worsening of old ones -- compared with patients who took a sugar pill. The group that received the drug also had a 36% reduction in disability progression and a 33% reduction in brain atrophy.
CALIFORNIA | LOCAL
March 26, 1995
With reference to your article on March 10, " 'Flesh-Eating' Disease Kills Agoura Man," I feel that this is irresponsible journalism. Reporting the occurrence is one thing, but quoting Sandra Tyson, the attorney for the family of another patient who died of the disease, is totally inflammatory and serves no purpose. I feel Tyson should be sanctioned by the Ventura County Bar Assn. for commenting on a case of which she has no connection and knows no specific facts of the medical problems involved with same.
April 3, 1988
Learning how to drink is of no use to an alcoholic. Learning how to live is. To Fingarette, I have this to say: Please stop trying to help us, for in actuality, you are helping to kill us, and we can do that well enough on our own. ROBIN S. HECKLE Los Angeles
CALIFORNIA | LOCAL
February 9, 2008 |
Having been absent from the Legislature for nearly two weeks, State Assemblywoman Sharon Runner (R-Lancaster) said through a spokeswoman Friday that she has been diagnosed with a rare but manageable disease that affects her autoimmune system. Runner, best known as an author of the state law requiring tracking of sex offenders, has been diagnosed with limited scleroderma, which normally affects the skin, but in her case has also caused lung problems, said spokeswoman Kayla Garcia. As a result, when the 53-year-old lawmaker catches a cold, the effects on her breathing can be more severe.
November 30, 2010 |
Walking may put the brakes on cognitive decline in healthy older people as well as those with cognitive impairment, a new study finds. The ongoing study, which spans 20 years, also quantified how much walking is necessary to keep brain volume up. Researchers followed 426 older adults for a number of years to see if there were changes in brain volume. Among the participants 299 were healthy, and 127 had cognitive impairments, including 83 with mild cognitive impairment, and 44 with Alzheimer's disease.
September 26, 2011 |
Men who don't have children may be at higher risk for cardiovascular disease, a study finds. The study, released Monday in the journal Human Reproduction , followed 137,903 male married or previously married AARP members for an average of about 10 years. At the beginning of the study, the participants, whose average age was about 63, had no history of heart disease, and 92% had fathered at least one child. Half had three or more children. During the course of the study, 3,082 men died due to cardiovascular causes.
February 7, 2011 |
A Boston researcher will receive a $1-million prize from the Prize4Life foundation's ALS Biomarker Challenge, an effort to develop new ways to monitor the progression of amyotrophic lateral sclerosis to make it easier to test potential drugs for the disease. The prize is believed to be the biggest-ever challenge award related to a medical condition, but Prize4Life estimates it could halve the cost of clinical trials for new ALS drugs. Dr. Seward Rutkove of Beth Israel Deaconess Medical Center will receive the award formally in June.